Filing Details
- Accession Number:
- 0001144204-11-045470
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-08-11 07:39:39
- Reporting Period:
- 2011-08-10
- Filing Date:
- 2011-08-11
- Accepted Time:
- 2011-08-11 07:39:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1381064 | Jr Wyche Fowler | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-08-10 | 5,000 | $3.07 | 125,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the weighted average purchase price. The range of prices for such transactions is $3.0682 to $3.0700. The reporting person effected multiple same-way open market purchases on the same day at different prices through a trade order executed by a broker dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission Staff, the issuer or a stakeholder of the issuer, full information regarding the number of shares purchased at each separate price.
- Of the 125,000 shares, 25,000 shares are restricted common stock.
Billionaire Hedge Funds
